(Total Views: 309)
Posted On: 08/28/2019 9:55:39 AM
Post# of 25525

$SNGX News Article - Soligenix Announces Positive Recommendation by Independent Data Monitoring Committee on its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer https://marketwirenews.com/news-releases/soli...92859.html


My Twitter: WhyteStocks